These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 38905884

  • 1. Design, synthesis and biological evaluation of novel naphthoquinothiazole derivatives as potent antitumor agents through inhibiting STAT3.
    Fan D, Liu P, Li Z, He X, Zhang L, Jiang W, Ang W, Yang T.
    Bioorg Chem; 2024 Sep; 150():107565. PubMed ID: 38905884
    [Abstract] [Full Text] [Related]

  • 2. Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting STAT3 and elevating ROS level.
    Zhang L, Liu P, Jiang Y, Fan D, He X, Zhang J, Luo B, Sui J, Luo Y, Fu X, Yang T.
    Eur J Med Chem; 2024 Jun 05; 272():116448. PubMed ID: 38704936
    [Abstract] [Full Text] [Related]

  • 3. A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3).
    Li C, Chen C, An Q, Yang T, Sang Z, Yang Y, Ju Y, Tong A, Luo Y.
    Eur J Med Chem; 2019 Jan 15; 162():543-554. PubMed ID: 30472602
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition.
    Li N, Ou J, Bao N, Chen C, Shi Z, Chen L, Sun J.
    Bioorg Chem; 2020 Nov 15; 104():104208. PubMed ID: 32919131
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis and biological evaluation of novel potent STAT3 inhibitors based on BBI608 for cancer therapy.
    Feng KR, Wang F, Shi XW, Tan YX, Zhao JY, Zhang JW, Li QH, Lin GQ, Gao D, Tian P.
    Eur J Med Chem; 2020 Sep 01; 201():112428. PubMed ID: 32603980
    [Abstract] [Full Text] [Related]

  • 6. Natural Product-Inspired Discovery of Naphthoquinone-Furo-Piperidine Derivatives as Novel STAT3 Inhibitors for the Treatment of Triple-Negative Breast Cancer.
    Fan C, Lou S, Shen C, Liao J, Ni H, Chen S, Zhu Z, Hu X, Xie W, Zhao H, Cui S.
    J Med Chem; 2024 Sep 12; 67(17):15291-15310. PubMed ID: 39226127
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and activity of novel 2,6-disubstituted purine derivatives, potential small molecule inhibitors of signal transducer and activator of transcription 3.
    Wang X, He Q, Wu K, Guo T, Du X, Zhang H, Fang L, Zheng N, Zhang Q, Ye F.
    Eur J Med Chem; 2019 Oct 01; 179():218-232. PubMed ID: 31254923
    [Abstract] [Full Text] [Related]

  • 8. Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells.
    Löcken H, Clamor C, Müller K.
    J Nat Prod; 2018 Jul 27; 81(7):1636-1644. PubMed ID: 30003778
    [Abstract] [Full Text] [Related]

  • 9. Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors.
    Gao D, Jin N, Fu Y, Zhu Y, Wang Y, Wang T, Chen Y, Zhang M, Xiao Q, Huang M, Li Y.
    Eur J Med Chem; 2021 Apr 15; 216():113333. PubMed ID: 33689932
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis and activity of BBI608 derivatives targeting on stem cells.
    Zhou Q, Peng C, Du F, Zhou L, Shi Y, Du Y, Liu D, Sun W, Zhang M, Chen G.
    Eur J Med Chem; 2018 May 10; 151():39-50. PubMed ID: 29604543
    [Abstract] [Full Text] [Related]

  • 11. LL1, a novel and highly selective STAT3 inhibitor, displays anti-colorectal cancer activities in vitro and in vivo.
    Liu Z, Wang H, Guan L, Lai C, Yu W, Lai M.
    Br J Pharmacol; 2020 Jan 10; 177(2):298-313. PubMed ID: 31499589
    [Abstract] [Full Text] [Related]

  • 12. Identification of New Shikonin Derivatives as Antitumor Agents Targeting STAT3 SH2 Domain.
    Qiu HY, Zhu X, Luo YL, Lin HY, Tang CY, Qi JL, Pang YJ, Yang RW, Lu GH, Wang XM, Yang YH.
    Sci Rep; 2017 Jun 06; 7(1):2863. PubMed ID: 28588262
    [Abstract] [Full Text] [Related]

  • 13. 10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation.
    Zhao Q, Bi Y, Zhong J, Li X, Guo J, Liu YX, Pan LR, Tan Y, Deng ZS, Yu XJ.
    Acta Pharmacol Sin; 2021 May 06; 42(5):791-800. PubMed ID: 32868906
    [Abstract] [Full Text] [Related]

  • 14. Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy.
    Zhang W, Guo J, Li S, Ma T, Xu D, Han C, Liu F, Yu W, Kong L.
    Sci Rep; 2017 Apr 11; 7():46352. PubMed ID: 28397855
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and biological evaluation of celastrol derivatives as potent antitumor agents with STAT3 inhibition.
    Xu S, Fan R, Wang L, He W, Ge H, Chen H, Xu W, Zhang J, Xu W, Feng Y, Fan Z.
    J Enzyme Inhib Med Chem; 2022 Dec 11; 37(1):236-251. PubMed ID: 34894961
    [Abstract] [Full Text] [Related]

  • 16. Synthesis, Antiproliferative Activity and Molecular Docking Analysis of Both Enantiomerically Pure Decursin Derivatives as Anticancer Agents.
    Ahn J, Hwang HH, Jung SY, Lee JY, Kim C, Choi HM, Gwon MJ, Kim MJ, Kwon Y, Woo J, Park B, Ko SG, Lee JY.
    Chem Pharm Bull (Tokyo); 2024 May 25; 72(5):498-506. PubMed ID: 38735699
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, and biological evaluation of indole-based hydroxamic acid derivatives as histone deacetylase inhibitors.
    Jiang BE, Hu J, Liu H, Liu Z, Wen Y, Liu M, Zhang HK, Pang X, Yu LF.
    Eur J Med Chem; 2022 Jan 05; 227():113893. PubMed ID: 34656899
    [Abstract] [Full Text] [Related]

  • 18. New naphthalene derivatives induce human lung cancer A549 cell apoptosis via ROS-mediated MAPKs, Akt, and STAT3 signaling pathways.
    Xu WT, Shen GN, Luo YH, Piao XJ, Wang JR, Wang H, Zhang Y, Li JQ, Feng YC, Zhang Y, Zhang T, Wang SN, Wang CY, Jin CH.
    Chem Biol Interact; 2019 May 01; 304():148-157. PubMed ID: 30871965
    [Abstract] [Full Text] [Related]

  • 19. 2'-Hydroxycinnamaldehyde inhibits proliferation and induces apoptosis via signal transducer and activator of transcription 3 inactivation and reactive oxygen species generation.
    Yoon YJ, Kim YH, Lee YJ, Choi J, Kim CH, Han DC, Kwon BM.
    Cancer Sci; 2019 Jan 01; 110(1):366-378. PubMed ID: 30375708
    [Abstract] [Full Text] [Related]

  • 20. Discovery, synthesis, and evaluation of small-molecule signal transducer and activator of transcription 3 inhibitors.
    Shi ZB, Zhao D, Huang YY, Du Y, Cao XR, Gong ZN, Zhao R, Li JX.
    Chem Pharm Bull (Tokyo); 2012 Jan 01; 60(12):1574-80. PubMed ID: 23207637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.